Cargando…

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine

Cystic fibrosis (CF) is an inherited disorder where individual disease etiology and response to therapeutic intervention is impacted by CF transmembrane regulator (CFTR) mutations and other genetic modifiers. CFTR regulates multiple mechanisms in a diverse range of epithelial tissues. In this Review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awatade, Nikhil T., Wong, Sharon L., Hewson, Chris K., Fawcett, Laura K., Kicic, Anthony, Jaffe, Adam, Waters, Shafagh A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293199/ https://www.ncbi.nlm.nih.gov/pubmed/30581387 http://dx.doi.org/10.3389/fphar.2018.01429

Ejemplares similares

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
por: Allan, Katelin M., et al.
Publicado: (2021)

Novel Antioxidant Therapy with the Immediate Precursor to Glutathione, γ-Glutamylcysteine (GGC), Ameliorates LPS-Induced Cellular Stress in In Vitro 3D-Differentiated Airway Model from Primary Cystic Fibrosis Human Bronchial Cells
por: Hewson, Chris K., et al.
Publicado: (2020)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis
por: Trend, Stephanie, et al.
Publicado: (2018)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
por: Fawcett, Laura K., et al.
Publicado: (2021)

Personalized or Precision Medicine? The Example of Cystic Fibrosis
por: Marson, Fernando A. L., et al.
Publicado: (2017)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator
por: Villamizar, Olga, et al.
Publicado: (2019)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
por: Berical, Andrew, et al.
Publicado: (2019)

Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator
por: Villamizar, Olga, et al.
Publicado: (2021)

Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
por: Awatade, Nikhil T., et al.
Publicado: (2014)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activity
por: Wong, Sharon L., et al.
Publicado: (2021)

Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and Research
por: Fawcett, Laura K., et al.
Publicado: (2023)

Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
por: Delpiano, Livia, et al.
Publicado: (2018)

β-Sitosterol Reduces the Expression of Chemotactic Cytokine Genes in Cystic Fibrosis Bronchial Epithelial Cells
por: Lampronti, Ilaria, et al.
Publicado: (2017)

Ouabain Mimics Low Temperature Rescue of F508del-CFTR in Cystic Fibrosis Epithelial Cells
por: Zhang, Donglei, et al.
Publicado: (2012)

Animal Models in the Pathophysiology of Cystic Fibrosis
por: Semaniakou, Anna, et al.
Publicado: (2019)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Enhancing Cystic Fibrosis Immune Regulation
por: van Heeckeren, Anna M., et al.
Publicado: (2021)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

Gene therapy for cystic fibrosis: Challenges and prospects
por: Sui, Hongshu, et al.
Publicado: (2022)

Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect
por: Wong, Sharon L., et al.
Publicado: (2022)

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Genetic Influences on Cystic Fibrosis Lung Disease Severity
por: Weiler, Colleen A., et al.
Publicado: (2013)

TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
por: Kunzelmann, Karl, et al.
Publicado: (2019)

Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
por: Esposito, Susanna, et al.
Publicado: (2019)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
por: Patergnani, Simone, et al.
Publicado: (2020)

Update on Calcium Signaling in Cystic Fibrosis Lung Disease
por: Rimessi, Alessandro, et al.
Publicado: (2021)

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
por: Ensinck, Marjolein, et al.
Publicado: (2021)

Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Yizi, et al.
Publicado: (2022)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
por: Mok, L. Clara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uch3m17pe73out5jldm70rc8ng